Install Free Gold Price Widget!
Install Free Gold Price Widget!
Install Free Gold Price Widget!
|
- UpToDate
This topic discusses the clinical significance of RBC alloantibodies other than anti-RhD during pregnancy Separate topics discuss RhD alloimmunization, fetal transfusion, and postnatal management of HDFN
- Learn how UpToDate can help you.
This topic review discusses the clinical significance of RBC alloantibodies other than anti-RhD during pregnancy … complicate the evaluation and management of a pregnancy include autoimmune hemolytic anemia (AIHA) in the mother,…
- UpToDate
Anti-Ro SSA antibodies may be the only autoantibodies present in a subset of patients with antinuclear antibody (ANA)-negative SLE Additionally, anti-Ro SSA antibodies (with or without anti-La SSB antibodies) identify pregnant women who are at increased risk of having a child with neonatal lupus (NL)
- UpToDate
Prevention of RhD alloimmunization in pregnant and postpartum patients through the use of anti-D immune globulin
- RhD alloimmunization in pregnancy: Management - UpToDate
In pregnancies with HDFN, appropriate pregnancy monitoring and intervention can markedly reduce adverse fetal and neonatal outcomes This topic provides our approach to management of pregnant patients with RhD alloimmunization
- The anti-Ro SSA and anti-La SSB antigen-antibody systems
Additionally, anti-Ro SSA antibodies (with or without anti-La SSB antibodies) identify pregnant women who are at increased risk of having a child with neonatal lupus syndrome (see "Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis") Anti-Ro SSA antibodies may also be the only autoantibodies present in a subset
- UpToDate
This topic will discuss the diagnosis of OAPS and management of pregnant patients with thrombotic APS and or OAPS who are pregnant, postpartum, or attempting to conceive using assisted reproductive technology (ART); their potential pregnancy outcomes will also be discussed
- RhD alloimmunization: Prevention in pregnant and postpartum . . . - UpToDate
Widespread use of anti-D immune globulin (Rh o (D) immune globulin) during pregnancy and postpartum has dramatically reduced, but not eliminated, D alloimmunization caused by fetal RBCs that have gained access to the maternal circulation
|
|
|